Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Sporn

Showing results (51-60 of 112) with videos related to

Pageof 12
Sort By:
Pharmacological Research|August 5, 2015
Novel synthetic pyridyl analogues of CDDO-Imidazolide are useful new tools in cancer preventionMartine Cao, Evans O Onyango, Charlotte R Williams, et al.
The Journal of Clinical Investigation|May 20, 2014
Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesisSung Hee Choi, Byung-Gyu Kim, Janet Robinson, et al.
Molecular Cancer|June 9, 2006
CDDO-Imidazolide inhibits growth and survival of c-Myc-induced mouse B cell and plasma cell neoplasmsSeong-Su Han, Liangping Peng, Seung-Tae Chung, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2002
A novel dicyanotriterpenoid, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-onitrile, active at picomolar concentrations for inhibition of nitric oxide productionTadashi Honda, Yukiko Honda, Frank G Favaloro, et al.
NPJ Breast Cancer|November 9, 2019
Retinoid X receptor agonist LG100268 modulates the immune microenvironment in preclinical breast cancer modelsAna S Leal, Kayla Zydeck, Sarah Carapellucci, et al.
The Journal of Biological Chemistry|February 20, 2008
The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid-imidazolide alters transforming growth factor beta-dependent signaling and cell migration by affecting the cytoskeleton and the polarity complexCiric To, Sarang Kulkarni, Tony Pawson, et al.
The Journal of Rheumatology|March 17, 2007
The synthetic triterpenoid TP-222 inhibits RANKL stimulation of osteoclastogenesis and matrix metalloproteinase-9 expressionRoy A Fava, Sarah Elliott, Lauren Raymond, et al.
Free Radical Biology & Medicine|May 7, 2011
Nrf2 has a protective role against neuronal and capillary degeneration in retinal ischemia-reperfusion injuryYanhong Wei, Junsong Gong, Takeshi Yoshida, et al.
Molecular Pharmacology|January 13, 2006
2-cyano-3,12-dioxooleana-1,9(11)-diene-28-oic acid disrupts microtubule polymerization: a possible mechanism contributing to apoptosisRobin D Couch, Neil J Ganem, Ming Zhou, et al.
The Journal of Clinical Investigation|September 14, 2011
Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in miceTangying Lu, Rupal Ramakrishnan, Soner Altiok, et al.
Pageof 12

Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
Pharmacological Research|August 5, 2015
Novel synthetic pyridyl analogues of CDDO-Imidazolide are useful new tools in cancer preventionMartine Cao, Evans O Onyango, Charlotte R Williams, et al.
The Journal of Clinical Investigation|May 20, 2014
Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesisSung Hee Choi, Byung-Gyu Kim, Janet Robinson, et al.
Molecular Cancer|June 9, 2006
CDDO-Imidazolide inhibits growth and survival of c-Myc-induced mouse B cell and plasma cell neoplasmsSeong-Su Han, Liangping Peng, Seung-Tae Chung, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2002
A novel dicyanotriterpenoid, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-onitrile, active at picomolar concentrations for inhibition of nitric oxide productionTadashi Honda, Yukiko Honda, Frank G Favaloro, et al.
NPJ Breast Cancer|November 9, 2019
Retinoid X receptor agonist LG100268 modulates the immune microenvironment in preclinical breast cancer modelsAna S Leal, Kayla Zydeck, Sarah Carapellucci, et al.
The Journal of Biological Chemistry|February 20, 2008
The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid-imidazolide alters transforming growth factor beta-dependent signaling and cell migration by affecting the cytoskeleton and the polarity complexCiric To, Sarang Kulkarni, Tony Pawson, et al.
The Journal of Rheumatology|March 17, 2007
The synthetic triterpenoid TP-222 inhibits RANKL stimulation of osteoclastogenesis and matrix metalloproteinase-9 expressionRoy A Fava, Sarah Elliott, Lauren Raymond, et al.
Free Radical Biology & Medicine|May 7, 2011
Nrf2 has a protective role against neuronal and capillary degeneration in retinal ischemia-reperfusion injuryYanhong Wei, Junsong Gong, Takeshi Yoshida, et al.
Molecular Pharmacology|January 13, 2006
2-cyano-3,12-dioxooleana-1,9(11)-diene-28-oic acid disrupts microtubule polymerization: a possible mechanism contributing to apoptosisRobin D Couch, Neil J Ganem, Ming Zhou, et al.
The Journal of Clinical Investigation|September 14, 2011
Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in miceTangying Lu, Rupal Ramakrishnan, Soner Altiok, et al.
Pageof 12